Universität des Saarlandes

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.uni-saarland.de

Clinical Trials

Adherence to Medication in Patients With Acute Decompensated Heart Failure

Recruiting

Conditions: Acute Decompensated Heart Failure

First Posted Date: 2024-06-14

Last Posted Date: 2024-06-20

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 100

Registration Number: NCT06459115

Locations: 🇩🇪
Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University, Homburg, Germany

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Recruiting

Conditions: Acute Decompensated Heart Failure

Interventions: Drug: Recompensation (guideline directed medical therapy)

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-20

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 12

Registration Number: NCT06453577

Locations: 🇩🇪
Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University, Homburg, Germany

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Completed

Conditions: Primary Prostate Urothelial Cancer
Benign Prostatic Hyperplasia

Interventions: Other: Plasma concentration of choline

First Posted Date: 2024-04-23

Last Posted Date: 2024-04-25

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 350

Registration Number: NCT06380062

Locations: 🇩🇪
University of Saarland, Homburg, Saarland, Germany

Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

Phase 2

Recruiting

Conditions: Extensive-stage Small-cell Lung Cancer

Interventions: Radiation: Thoracic Radiochemotherapy
Drug: durvalumab
Radiation: Stereotactic radiotherapy of further tumor locations
Drug: Chemotherapy

First Posted Date: 2024-01-25

Last Posted Date: 2024-04-05

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 43

Registration Number: NCT06223711

Locations: 🇩🇪
Kliniken Maria Hilf, Mönchengladbach, NRW, Germany
🇩🇪
Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology, Homburg, Saarland, Germany
🇩🇪
University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy, Regensburg, Bavaria, Germany

and more 2 locations

Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis

Recruiting

Conditions: Acute Kidney Injury

First Posted Date: 2023-12-22

Last Posted Date: 2023-12-22

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 1000

Registration Number: NCT06180551

Locations: 🇩🇪
Universitätsklinikum des Saarlandes, Homburg, Saarland, Germany

A Combinatorial Biomarker for Infection Diagnosis in Children

Recruiting

Conditions: Respiratory Tract Infections
Fever

Interventions: Diagnostic Test: BV

First Posted Date: 2023-08-02

Last Posted Date: 2023-08-02

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 770

Registration Number: NCT05971901

Locations: 🇩🇪
Saarland University, Homburg, Germany
🇩🇪
Universitätsklinikum Bonn, Bonn, Germany
🇩🇪
Sana Kliniken, Berlin, Germany

and more 1 locations

Investigating the Effect of Yoga-based Breathing Styles on the Human Brain, With a Focus on Memory

Not Applicable

Recruiting

Conditions: Hypoventilation
Hyperventilation

Interventions: Other: Mouth-breathing training
Other: Nose-breathing training

First Posted Date: 2023-05-06

Last Posted Date: 2024-04-17

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 75

Registration Number: NCT05846425

Locations: 🇩🇪
Department of Diagnostic and Interventional Neuroradiology, Saarland University Medical Center, Homburg, Saarland, Germany

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Phase 3

Recruiting

Conditions: Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma

Interventions: Drug: R-miniCHOP
Drug: R-miniCHOP + Acalabrutinib

First Posted Date: 2023-04-20

Last Posted Date: 2023-08-31

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 330

Registration Number: NCT05820841

Locations: 🇩🇪
Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
🇩🇪
Rheinland Klinikum-Lukaskrankenhaus Neuss, Neuss, Germany
🇩🇪
MVZ am Klinikum Aschaffenburg, Aschaffenburg, Germany

and more 14 locations

Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation

Not Applicable

Not yet recruiting

Conditions: Catheter-Related Infections

Interventions: Drug: Vancomycine

First Posted Date: 2022-12-15

Last Posted Date: 2022-12-15

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 42

Registration Number: NCT05651464

Locations: 🇩🇪
University Hospital of Saarland, Homburg, Saarland, Germany

Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC

Phase 2

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab
Drug: Lenvatinib

First Posted Date: 2022-06-27

Last Posted Date: 2024-08-02

Lead Sponsor: Universität des Saarlandes

Target Recruit Count: 50

Registration Number: NCT05433116

Locations: 🇩🇪
University Hospital Ulm, Otolaryngology & Head and Neck Surgery, Ulm, Baden-Württemberg, Germany
🇩🇪
University Hospital Düsseldorf, Radiation Oncology, Düsseldorf, Northrhine-Westphalia, Germany
🇩🇪
University Hospital Frankfurt/M, Center for Radiology, Frankfurt, Hesse, Germany

and more 7 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy